List of Tables

Table 1. Compounded Bioidentical Hormone Therapy Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Compounded Bioidentical Hormone Therapy Market Restraints

Table 3. Compounded Bioidentical Hormone Therapy Market Trends

Table 4. Compounded Bioidentical Hormone Therapy Industry Policy

Table 5. Global Compounded Bioidentical Hormone Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Compounded Bioidentical Hormone Therapy Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Compounded Bioidentical Hormone Therapy Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Compounded Bioidentical Hormone Therapy Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Compounded Bioidentical Hormone Therapy Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Compounded Bioidentical Hormone Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Compounded Bioidentical Hormone Therapy Mergers & Acquisitions, Expansion Plans

Table 12. Global Compounded Bioidentical Hormone Therapy Manufacturers Product Type

Table 13. Head Office and Compounded Bioidentical Hormone Therapy Production Site of Key Manufacturer

Table 14. Compounded Bioidentical Hormone Therapy Capacity of Major Manufacturers and Future Plan

Table 15. China Compounded Bioidentical Hormone Therapy Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Compounded Bioidentical Hormone Therapy Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Compounded Bioidentical Hormone Therapy Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Compounded Bioidentical Hormone Therapy Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Compounded Bioidentical Hormone Therapy Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Compounded Bioidentical Hormone Therapy Production by Region, 2020-2025, (K Units)

Table 21. Global Compounded Bioidentical Hormone Therapy Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Compounded Bioidentical Hormone Therapy Upstream (Raw Materials)

Table 23. Global Compounded Bioidentical Hormone Therapy Typical Customers

Table 24. Compounded Bioidentical Hormone Therapy Typical Distributors

Table 25. by Type, Global Compounded Bioidentical Hormone Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Compounded Bioidentical Hormone Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Compounded Bioidentical Hormone Therapy Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Compounded Bioidentical Hormone Therapy Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Compounded Bioidentical Hormone Therapy Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Compounded Bioidentical Hormone Therapy Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Compounded Bioidentical Hormone Therapy Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2020-2031

Table 35. SottoPelle Company Information, Head Office, Market Area, and Industry Position

Table 36. SottoPelle Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 37. SottoPelle Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. SottoPelle Company Profile and Main Business

Table 39. SottoPelle Recent Developments

Table 40. BioTE Medical Company Information, Head Office, Market Area, and Industry Position

Table 41. BioTE Medical Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 42. BioTE Medical Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. BioTE Medical Company Profile and Main Business

Table 44. BioTE Medical Recent Developments

Table 45. Advantage Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 46. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 47. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Advantage Pharmaceuticals Company Profile and Main Business

Table 49. Advantage Pharmaceuticals Recent Developments

Table 50. Full Life Wellness Center Company Information, Head Office, Market Area, and Industry Position

Table 51. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 52. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Full Life Wellness Center Company Profile and Main Business

Table 54. Full Life Wellness Center Recent Developments

Table 55. Neuva Aesthetics Company Information, Head Office, Market Area, and Industry Position

Table 56. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 57. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Neuva Aesthetics Company Profile and Main Business

Table 59. Neuva Aesthetics Recent Developments

Table 60. Defy Medical Company Information, Head Office, Market Area, and Industry Position

Table 61. Defy Medical Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 62. Defy Medical Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. Defy Medical Company Profile and Main Business

Table 64. Defy Medical Recent Developments

Table 65. Bio station Company Information, Head Office, Market Area, and Industry Position

Table 66. Bio station Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 67. Bio station Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Bio station Company Profile and Main Business

Table 69. Bio station Recent Developments

Table 70. Noven Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 71. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 72. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Noven Pharmaceuticals Company Profile and Main Business

Table 74. Noven Pharmaceuticals Recent Developments

Table 75. Novartis AG Company Information, Head Office, Market Area, and Industry Position

Table 76. Novartis AG Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 77. Novartis AG Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Novartis AG Company Profile and Main Business

Table 79. Novartis AG Recent Developments

Table 80. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 81. Pfizer Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 82. Pfizer Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. Pfizer Company Profile and Main Business

Table 84. Pfizer Recent Developments

Table 85. TherapeuticsMD Company Information, Head Office, Market Area, and Industry Position

Table 86. TherapeuticsMD Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 87. TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. TherapeuticsMD Company Profile and Main Business

Table 89. TherapeuticsMD Recent Developments

Table 90. Bayer AG Company Information, Head Office, Market Area, and Industry Position

Table 91. Bayer AG Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 92. Bayer AG Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. Bayer AG Company Profile and Main Business

Table 94. Bayer AG Recent Developments

Table 95. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position

Table 96. Novo Nordisk Compounded Bioidentical Hormone Therapy Models, Specifications, and Application

Table 97. Novo Nordisk Compounded Bioidentical Hormone Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 98. Novo Nordisk Company Profile and Main Business

Table 99. Novo Nordisk Recent Developments

List of Figures

Figure 1. Compounded Bioidentical Hormone Therapy Picture

Figure 2. Global Compounded Bioidentical Hormone Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Compounded Bioidentical Hormone Therapy Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Compounded Bioidentical Hormone Therapy Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Compounded Bioidentical Hormone Therapy Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Compounded Bioidentical Hormone Therapy Sales Quantity (K Units) & (2020-2031)

Figure 7. China Compounded Bioidentical Hormone Therapy Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Compounded Bioidentical Hormone Therapy Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Compounded Bioidentical Hormone Therapy Market Share of Global, 2020-2031

Figure 10. Global Compounded Bioidentical Hormone Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Compounded Bioidentical Hormone Therapy Key Participants, Market Share, 2024

Figure 12. Global Compounded Bioidentical Hormone Therapy Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Compounded Bioidentical Hormone Therapy Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Compounded Bioidentical Hormone Therapy Production Market Share & Forecast by Region, 2020-2031

Figure 15. Compounded Bioidentical Hormone Therapy Industry Chain

Figure 16. Compounded Bioidentical Hormone Therapy Procurement Model

Figure 17. Compounded Bioidentical Hormone Therapy Sales Model

Figure 18. Compounded Bioidentical Hormone Therapy Sales Channels, Direct Sales, and Distribution

Figure 19. Oestrogen

Figure 20. Progesterone

Figure 21. Testosterone

Figure 22. by Type, Global Compounded Bioidentical Hormone Therapy Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Compounded Bioidentical Hormone Therapy Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 25. by Type, Global Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Compounded Bioidentical Hormone Therapy Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 27. Hospital Pharmacies

Figure 28. Retail Pharmacies

Figure 29. Online Pharmacies

Figure 30. Others

Figure 31. by Application, Global Compounded Bioidentical Hormone Therapy Consumption Value, 2020-2031, US$ Million

Figure 32. by Application, Global Compounded Bioidentical Hormone Therapy Revenue Market Share, 2020-2031

Figure 33. by Application, Global Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 34. by Application, Global Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2020-2031

Figure 35. by Application, Global Compounded Bioidentical Hormone Therapy Price, 2020-2031, (US$/Unit)

Figure 36. By Region, Global Compounded Bioidentical Hormone Therapy Consumption Value Market Share, 2020-2031

Figure 37. By Region, Global Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2020-2031

Figure 38. North America Compounded Bioidentical Hormone Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 39. By Country, North America Compounded Bioidentical Hormone Therapy Consumption Value Market Share, 2024

Figure 40. Europe Compounded Bioidentical Hormone Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country, Europe Compounded Bioidentical Hormone Therapy Consumption Value Market Share, 2024

Figure 42. Asia Pacific Compounded Bioidentical Hormone Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country/Region, Asia Pacific Compounded Bioidentical Hormone Therapy Consumption Value Market Share, 2024

Figure 44. South America Compounded Bioidentical Hormone Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. By Country, South America Compounded Bioidentical Hormone Therapy Consumption Value Market Share, 2024

Figure 46. Middle East & Africa Compounded Bioidentical Hormone Therapy Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 47. United States Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 48. by Type, United States Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 49. by Application, United States Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 50. Europe Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 51. by Type, Europe Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 52. by Application, Europe Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 53. China Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 54. by Type, China Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 55. by Application, China Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 56. Japan Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 57. by Type, Japan Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 58. by Application, Japan Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 59. South Korea Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 60. by Type, South Korea Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 61. by Application, South Korea Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 62. Southeast Asia Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 63. by Type, Southeast Asia Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 64. by Application, Southeast Asia Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 65. India Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 66. by Type, India Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 67. by Application, India Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 68. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Quantity, 2020-2031, (K Units)

Figure 69. by Type, Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 70. by Application, Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Quantity Market Share, 2024 VS 2031

Figure 71. Research Methodology

Figure 72. Breakdown of Primary Interviews

Figure 73. Bottom-up Approaches

Figure 74. Top-down Approaches